Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying TherapyLA JOLLA, CA, (GLOBE ...
HOUSTON--(BUSINESS WIRE)--Tvardi Therapeutics, Inc. (“Tvardi”) will publicly present, for the first time, clinical results from the Phase 1 study of TTI-101, a STAT3 inhibitor, in relapsed/refractory ...
14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and ...
WALTHAM, Mass. & DURHAM, N.C.--(BUSINESS WIRE)--Life Edit ® Therapeutics Inc., an ElevateBio ® company focused on next-generation gene editing technologies and therapeutics, today announced the ...
Immix Biopharma, Inc. has announced that interim data from its Phase 1/2 NEXICART-2 trial of the CAR-T therapy NXC-201 for relapsed/refractory AL Amyloidosis will be presented at the 2025 American ...
ACNP abstracts are available on the conference website and the Company’s poster will be available on the Centessa website at https://investors.centessa.com/events-presentations after the poster ...
A scheduled meeting to discuss data centers in Warrick County, Indiana, has been cancelled.
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimislecel ...
Data visualization is a process in data analytics where visual representation communicates the data and insights to facilitate good data-driven decisions. Basically, data visualization is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results